Racaídas y fracasos en diabéticos mellitus con tratamiento tuberculoso. Estudio a realizar en el Centro de Salud # 1 del Area 8 períodos 2012-2015
Fecha
2016
Título de la revista
ISSN de la revista
Título del volumen
Editor
Universidad de Guayaquil. Facultad de Ciencias Médicas. Escuela de Medicina
Resumen
La tuberculosis es una enfermedad infecciosa, de las que causan más muerte en nuestro planeta, uno de los factores de riesgo para el desarrollo de la TB es la diabetes mellitus (DM). Los estudios realizados a pacientes con DM tipo 2 han dado como resultado, que el riesgo de desarrollar TB es 8 veces mayor con respecto a individuos no diabéticos. También se demostró que la DM tipo 2 incrementa el número de pacientes que fracasan al tratamiento. Pocos temas atraen, en especial a la humanidad que el referente a la mala salud y enfermedades, también es poco o casi nada lo que se ha escrito sobre la Tuberculosis en pacientes Diabéticos que debido a la complejidad de ser una enfermedad infecciosa y crónica provoca un alto índice de mortalidad en la población que tiene poco conocimiento de su tratamiento que incide en la población sobre todo de escasos recursos económicos. Por lo antes descrito se formuló como objetivo determinar si el binomio TB-DM2 influye en el fracaso del tratamiento antituberculoso, este estudio clínico teórico es de tipo no experimental u observacional. Se tomaron datos de fuentes documentales como son las historias clínicas de los pacientes pertenecientes al Centro de Salud #1 diagnosticados con tuberculosis con comorbilidad a diabetes durante el periodo 2012-2015. Durante este tiempo se tomó una muestra de 160 pacientes que cumplían con los criterios de inclusión de los cuales 13 pacientes presentaban Binomio TB-DM2. Según estadística de la OMS se calcula que un tercio de la población mundial padece este tipo de enfermedades que en cifras estadísticas alcanza 9.2 millones de personas que padecen esta enfermedad.
Tuberculosis is an infectious disease, which cause more death on our planet, one of the risk factors for developing TB is diabetes mellitus (DM). Studies in patients with type 2 diabetes have resulted, the risk of developing TB is 8 times higher compared to non-diabetic individuals. It was also demonstrated that type 2 DM increases the number of patients who fail to treatment. Few issues attract, especially to humanity that the reference to poor health and disease, is also little or almost nothing has been written about tuberculosis in diabetic patients due to the complexity of being a chronic infectious disease and causes high mortality rate in the population has little knowledge of treatment that affects the population especially low income. It was formulated as described above objective determine whether the dual TB-DM2 influences the failure of tuberculosis treatment, this theoretical clinical study is not experimental or observational. Data were taken documentary sources such as medical records of patients from the Health Center No. 1 diagnosed with tuberculosis comorbidity diabetes during 2012-2015. During this time a sample of 160 patients who met the inclusion criteria of which 13 patients had Binomio TB-DM2 was taken. According to WHO statistics it is estimated that one third of the world population suffers from these diseases in statistical figures reached 9.2 million people suffering from this disease.
Tuberculosis is an infectious disease, which cause more death on our planet, one of the risk factors for developing TB is diabetes mellitus (DM). Studies in patients with type 2 diabetes have resulted, the risk of developing TB is 8 times higher compared to non-diabetic individuals. It was also demonstrated that type 2 DM increases the number of patients who fail to treatment. Few issues attract, especially to humanity that the reference to poor health and disease, is also little or almost nothing has been written about tuberculosis in diabetic patients due to the complexity of being a chronic infectious disease and causes high mortality rate in the population has little knowledge of treatment that affects the population especially low income. It was formulated as described above objective determine whether the dual TB-DM2 influences the failure of tuberculosis treatment, this theoretical clinical study is not experimental or observational. Data were taken documentary sources such as medical records of patients from the Health Center No. 1 diagnosed with tuberculosis comorbidity diabetes during 2012-2015. During this time a sample of 160 patients who met the inclusion criteria of which 13 patients had Binomio TB-DM2 was taken. According to WHO statistics it is estimated that one third of the world population suffers from these diseases in statistical figures reached 9.2 million people suffering from this disease.
Descripción
Palabras clave
DIABETES MELLITUS, TUBERCULOSIS, CENTRO DE SALUD NO.1, CANTON GUAYAQUIL, ECUADOR, ESTUDIO OBSERVACIONAL